Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Annals of Hematology
|
August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
M Witzens-Harig, G Hess, J Atta, et al.
Leukemia
|
February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicing
C R Stadler, N Vegi, M A Mulaw, et al.
Leukemia
|
June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice
A J Deshpande, A Rouhi, Y Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, et al.
Leukemia
|
September 27, 2008
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C Buske, E Hoster, M Dreyling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A J M Ferreri, G Illerhaus, J K Doorduijn, et al.
Leukemia
|
June 1, 2011
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
T Herold, V Jurinovic, K H Metzeler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
K Hübel, M Bower, I Aurer, et al.
Blood Cancer Journal
|
December 10, 2016
MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia
K Krowiorz, J Ruschmann, C Lai, et al.
Seminars in Hematology
|
May 5, 2023
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
S D'Sa, J V Matous, R Advani, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Annals of Hematology
|
August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
M Witzens-Harig, G Hess, J Atta, et al.
Leukemia
|
February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicing
C R Stadler, N Vegi, M A Mulaw, et al.
Leukemia
|
June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice
A J Deshpande, A Rouhi, Y Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, et al.
Leukemia
|
September 27, 2008
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
C Buske, E Hoster, M Dreyling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A J M Ferreri, G Illerhaus, J K Doorduijn, et al.
Leukemia
|
June 1, 2011
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
T Herold, V Jurinovic, K H Metzeler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
K Hübel, M Bower, I Aurer, et al.
Blood Cancer Journal
|
December 10, 2016
MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia
K Krowiorz, J Ruschmann, C Lai, et al.
Seminars in Hematology
|
May 5, 2023
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
S D'Sa, J V Matous, R Advani, et al.
Page
of 10